Snap Inc vs BIO-TECHNE Corp — how do they compare? Snap Inc trades at $4.56 (market cap $7.67B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Snap Inc pays none. Which is the better fit depends on your goals.
| SNAP | TECH | |
|---|---|---|
Market Cap | $7.67B | $11.16B |
Sector | Media | Health |
52-Week High | $10.35 | $72.12 |
52-Week Low | $3.93 | $43.31 |
Enterprise Value | $9.05B | $11.24B |
Dividend Yield | — | 0.45% |
Trailing returns across standard periods
Latest headlines on both assets
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →